Catalyst Funds Management’s Exact Sciences EXAS Stock Holding History

Catalyst Funds Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,400	Closed	-$244K	–	631
2025 Q4	$244K	Buy	+2,400	New	+$193K	0.06%	262
2025 Q3	–	Sell	-8,805	Closed	-$468K	–	547
2025 Q2	$468K	Buy	+8,805	New	+$447K	0.13%	211
2024 Q4	–	Sell	-10,500	Closed	-$715K	–	645
2024 Q3	$715K	Buy	+10,500	New	+$593K	0.16%	100

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Catalyst Funds Management's EXAS Position: Q1 2026 in Review

Catalyst Funds Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,400 shares — an estimated $244K sold.

Catalyst Funds Management first reported a position in EXAS in Q3 2024 and held it in 3 quarters. The position peaked at $715K in Q3 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Catalyst Funds Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Catalyst Funds Management sold 2,400 Exact Sciences shares in Q1 2026, an estimated $244K.
Catalyst Funds Management first reported a position in Exact Sciences in Q3 2024 and held it in 3 quarters.
Catalyst Funds Management's Exact Sciences position peaked at $715K in Q3 2024.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Catalyst Funds Management's 13F filing for Q1 2026, filed 11 May 2026.